Medicare Card, Panel recommends changing name of common disorder in women
December 7th, 2013
An independent panel convened by the National Institutes of Health has concluded that the name of a common hormone disorder in women, polycystic ovary syndrome (PCOS), causes confusion and is a barrier to research progress and effective patient care.
Related posts:
- Women sought for NIH study of infertility disorder Young women in the Washington, D.C., area who have polycystic ovarian syndrome (PCOS) are encouraged to take part in a study at the National Institutes of Health on the possible role of the adrenal glands in the disorder. MedicareCard.com has been serving consumers for several years with a primary emphasis on Medicare information and assistance. […]...
- Panel endorses active monitoring and delay of treatment for low-risk prostate cancer An independent panel convened this week by the National Institutes of Health has concluded that many men with localized, low-risk prostate cancer should be closely monitored, permitting treatment to be delayed until warranted by disease progression....
- Progestin treatment for polycystic ovarian syndrome may reduce pregnancy chances The hormone progestin, often given as a first step in infertility treatment for polycystic ovary syndrome (PCOS), appears to decrease the odds of conception and of giving birth, according to a study by a National Institutes of Health research network....
- MedicareCard.com News – Independent Panel Finds Insufficient Evidence to Support Preventive Measures for Alzheimer’s Disease Many preventive measures for cognitive decline and for preventing Alzheimer's disease—mental stimulation, exercise, and a variety of dietary supplements...
- Medicare, Independent panel discourages routine use of treatment regimen for premature infants Premature infants often suffer from respiratory problems due to their underdeveloped lungs. Over the past decade, many of these infants have been treated with inhaled nitric oxide — a treatment designed to ease breathing by widening blood vessels in the lungs. This week, an independent panel convened by the National Institutes of Health determined that […]...
- Medicare Card, Autism Progress Dr. Insel highlights key recent findings in research on autism spectrum disorders. Every year the Interagency Autism Coordinating Committee (IACC) updates its Strategic Plan for Autism Spectrum Disorder Research, identifying progress and new opportunities across the range of autism spectrum disorder (ASD) research. Each year this task gets more difficult. In 2012, the speed of […]...
- Science News, Experimental Medication Lifts Depression Symptoms in Bipolar Disorder Within an Hour People with treatment-resistant bipolar disorder experienced relief from symptoms of depression in as little as 40 minutes after an intravenous dose of the anesthetic medication ketamine in a preliminary study; while the patient group was small, this work adds to evidence that compounds in the class to which ketamine belongs have potential as rapid and […]...
- Drug halts organ damage in inflammatory genetic disorder A new study shows that Kineret (anakinra), a medication approved for the treatment of rheumatoid arthritis, is effective in stopping the progression of organ damage in people with neonatal-onset multisystem inflammatory disease (NOMID). This rare and debilitating genetic disorder causes persistent inflammation and ongoing tissue damage. The research was performed by scientists at the National […]...
- Medicare, Medicare Card, Study Finds Two Sling Surgeries, Equally Effective for Bladder Control in Women Two common operations for stress urinary incontinence (SUI) help women achieve similar levels of dryness, according to a team of urologists and urogynecologists who compared the treatments in a large U.S. trial supported by the National Institutes of Health. The study is being released online May 17, 2010, by the New England Journal of Medicine […]...
- Vitamin D Status is Not Associated with Risk for Less Common Cancers Despite hopes that higher blood levels of vitamin D might reduce cancer risk, a large study finds no protective effect against non-Hodgkin lymphoma or cancer of the endometrium, esophagus, stomach, kidney, ovary, or pancreas. In this study, carried out by researchers from the National Cancer Institute (NCI), part of the National Institutes of Health, and […]...
- Panel Calls for Reducing Colorectal Cancer Deaths by Striking Down Barriers to Screening Colorectal cancer is the second leading cause of cancer-related deaths in the United States. Despite evidence and guidelines supporting the value of screening for this disease, rates of screening for colorectal cancer are consistently lower than those for other types of cancer, particularly breast and cervical. ...
- VOICE HIV prevention study in women A large-scale clinical trial evaluating whether daily use of an oral tablet or vaginal gel containing antiretroviral drugs can prevent HIV infection in women is being modified because an interim review found that the study cannot show that one of the study products, oral tenofovir, marketed under the trade name Viread, is effective....
- Medicare Card, Comparable effectiveness shown for two common sudden deafness treatments Direct injection of steroids into the middle ear for the treatment of sudden deafness was shown to be no more or less effective than oral steroids in restoring hearing levels in a large comparison study of patients. The study results appear in the May 25, 2011 issue of the Journal of the American Medical Association. […]...
- Order FREE Wiser Women Action Kit The Wiser Women Action Kit provides practical health tips for women on a range of topics, including cholesterol; diabetes; mammograms; osteoporosis; and health scams. Order a FREE kit for yourself and/or for the women in your life....
- Medicare Card, Scientists Identify Markers, Human Breast Cancer Cells, Linked to Development of an Aggressive, But Less Common Form of Breast Cancer Scientists have identified a group of surface markers on cells linked to an aggressive type of breast cancer called estrogen receptor-negative cancer. In this preliminary study, estrogen-negative breast cancer developed when three markers, CD44+, CD49fhi, and CD133hi were present simultaneously on the surface of human cells taken from breast cancer patients and transplanted into a […]...
Posted in MedicareCard Replacement | Tags: MEDICARE CARD